NCT00005628View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions
Sarcoma
Interventions
BIOLOGICAL

vitespen

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER